Advertisement
Screener

Arcus Biosciences, Inc. (RCUS) Auditor

Arcus Biosciences, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-25: Fiscal year end 2025-12-31; Auditor Ernst & Young, LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2025-02-25: Fiscal year end 2024-12-31; Auditor Ernst & Young, LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2024-02-21: Fiscal year end 2023-12-31; Auditor Ernst & Young, LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2023-02-28: Fiscal year end 2022-12-31; Auditor Ernst & Young, LLP; PCAOB firm ID 42; Location San Mateo, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-252025-12-31Ernst & Young, LLP42San Mateo, CaliforniaYes
2025-02-252024-12-31Ernst & Young, LLP42San Mateo, CaliforniaYes
2024-02-212023-12-31Ernst & Young, LLP42San Mateo, CaliforniaYes
2023-02-282022-12-31Ernst & Young, LLP42San Mateo, CaliforniaYes
2022-02-232021-12-31Ernst & Young, LLP42Redwood City, CaliforniaYes
2021-02-252020-12-31Ernst & Young LLPRedwood City, CaliforniaYes
2020-03-052019-12-31Ernst & Young LLPRedwood City, California
2019-03-052018-12-31Ernst & Young LLPRedwood City, California

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36